BRIEF-PNM Resources sets regular quarterly dividend of $0.2425 per share
* Sets regular quarterly dividend of $0.2425 per share Source text for Eikon: Further company coverage:
Dec 13 Paratek Pharmaceuticals Inc
* Paratek Pharmaceuticals Inc says projects its ongoing pivotal phase 3 clinical study will report top-line data during Q2 of 2017
* Paratek Pharmaceuticals - will be able to file new drug application for omadacycline for acute skin infections, pneumonia indications in H1 2018
* Press release - Paratek advances timing of top-line data for phase 3 community acquired bacterial pneumonia study to the second quarter of 2017 Source text for Eikon: Further company coverage:
Feb 24 Citigroup Inc on Friday said that U.S. government and regulatory agencies are investigating the bank's hiring practices.
* It will not be proceeding with non-brokered private placement announced January 20, 2017